Soligenix COVID-19 Vaccine, CiVax, Boosts Neutralizing Activity Against SARS-CoV-2, Including Delta And Omicron

CiVax™ booster vaccine administered seven months after primary vaccination with COVID-19 adenovirus vaccine shows rapid enhancement of neutralizing antibody responses in non-human primates Neutralizing
  • CiVax™ booster vaccine administered seven months after primary vaccination with COVID-19 adenovirus vaccine shows rapid enhancement of neutralizing antibody responses in non-human primates
  • Neutralizing antibodies against Delta and original strain increased by up to 27-fold within one week and up to 243-fold within three weeks
  • Omicron neutralizing antibody levels were undetectable prior to booster vaccination, and attained presumed protective levels within one week of vaccination
Total
0
Shares
Related Posts